Advanced acute myelogenous leukaemia (AML) during HAART-treated HIV disease, manifesting initially as a thyroid mass

Author： Manfredi Roberto Sabbatani Sergio Chiodo Francesco

ISSN： 0036-5548

Source： Scandinavian Journal of Infectious Diseases, Vol.37, Iss.10, 2005-10, pp. : 781-783

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Graves' disease during immune reconstitution in HIV-infected patients treated with HAART

By Vos F. Pieters G. Keuter M. van der Ven A.

Scandinavian Journal of Infectious Diseases, Vol. 38, Iss. 2, 2006-06 ,pp. : 124-126

Informa Healthcare

Access to resources Recommend Favorite

Outcome of children with acute myeloid leukaemia (AML) experiencing primary induction failure in the AIEOP AML 2002/01 clinical trial

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 171, Iss. 4, 2015-11 ,pp. : 566-573

John Wiley & Sons Inc

Access to resources Recommend Favorite

Promyelocytic Crisis of Chronic Myelogenous Leukaemia during Imatinib Mesylate Treatment

Acta Haematologica, Vol. 117, Iss. 4, 2006-12 ,pp. : 191-196

Karger

Access to resources Recommend Favorite

HIV-1-Associated Dementia During HAART Therapy

Recent Patents on CNS Drug Discovery, Vol. 3, Iss. 1, 2008-01 ,pp. : 23-33

Bentham Science Publishers

Access to resources Recommend Favorite

Detection of Minimal Residual Disease in Acute Myelogenous Leukemia

Acta Haematologica, Vol. 112, Iss. 1-2, 2004-06 ,pp. : 40-54

Karger

Access to resources Recommend Favorite